Amphetamine disrupts P50 suppression in normal subjects (Q41694096)

7 October 2017

Amphetamine disrupts P50 suppression in normal subjects (English)

1 reference

7 October 2017

Light GA

1

1 reference

7 October 2017

Malaspina D

2

1 reference

7 October 2017

Geyer MA

3

1 reference

7 October 2017

Luber BM

4

1 reference

7 October 2017

Coleman EA

5

1 reference

7 October 2017

Sackeim HA

6

1 reference

7 October 2017

Braff DL

7

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

7 October 2017

Biological Psychiatry

1 reference

7 October 2017

46

1 reference

7 October 2017

7

1 reference

7 October 2017

990-996

1 reference

Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Yohimbine impairs P50 auditory sensory gating in normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Modulation of the gating of auditory evoked potentials by norepinephrine: Pharmacological evidence obtained using a selective neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Auditory sensory gating in hippocampal neurons: a model system in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Test-retest reliability of the P50 mid-latency auditory evoked response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Sensorimotor gating and schizophrenia. Human and animal model studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

The reliability of P50 suppression as measured by the conditioning/testing ratio is vastly improved by dipole modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

The gamma band response may account for poor P50 suppression in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

The earth is round (p < .05).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Midlatency auditory evoked responses in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Brain imaging of schizophrenia--the dopamine hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Gender differences in gating of the auditory evoked potential in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Effects of P50 temporal variability on sensory gating in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Sensory gating deficits in schizophrenia: new results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

The "incredible shrinking" P50 event-related potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Effects of pharmacologic catecholamine manipulation on smooth pursuit eye movements in normals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Dopaminergic stimulation disrupts sensorimotor gating in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Gating of auditory P50 in schizophrenics: unique effects of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Antipsychotic drug doses and neuroleptic/dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Biochemical factors in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Effects of neonatal dopamine depletion on sensory inhibition in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Disruption of sensory gating by the alpha 2 selective noradrenergic antagonist yohimbine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Men are more inhibited than women by weak prepulses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Sensory gating deficits in parents of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Defects in auditory sensory gating and their apparent compensation in relatives of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Codistribution of a sensory gating deficit and schizophrenia in multi-affected families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

Replication of a P50 auditory gating deficit in Australian patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900034-7

10.1016/S0006-3223(99)00034-7

7 January 2021

Identifiers

DOI

1 reference

7 October 2017

1 reference